| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/27/2013 | CN101979564B RNAi fragment for interfering with object sequence and RNAi expression vector |
| 02/27/2013 | CN101979545B Nucleotide sequence and vector for directional cloning |
| 02/27/2013 | CN101967684B Sequencing library, preparation method thereof, and terminal sequencing method and device |
| 02/27/2013 | CN101921336B Monoclonal antibody against human alpha1 acid glycoprotein and preparation method thereof |
| 02/27/2013 | CN101842487B Fusion polynucleotide for biosynthesis of beta-carotene using bicistronic gene expression and method for producing beta-carotene using the same |
| 02/27/2013 | CN101701254B Primer used for pea PCR identification and PCR identification method |
| 02/27/2013 | CN101660003B Integrated detection DNA microarray chip for HBV, HCV and HIV-1 in blood |
| 02/27/2013 | CN101654685B Human Bcl-2 and human VEGF165 double-gene co-expression recombinant vector and building method thereof |
| 02/27/2013 | CN101613398B Surface lipoprotein of streptococcus suis type-2, preparation method thereof and application |
| 02/27/2013 | CN101568646B Primer set for gene amplification, gene amplification reagent containing the same and use thereof |
| 02/27/2013 | CN101497883B Expression production and separation purification of recombinant placenta growth factor and chemical marker thereof |
| 02/27/2013 | CN101395271B Aspartate aminotransferase gene and method for production of l-phosphinothricin |
| 02/27/2013 | CN101255424B Starter for epilepsy related SCN1A gene as well as construction method and clinical application thereof |
| 02/27/2013 | CN101220370B Bifidobacteria-bacillus coli shuttle expression vector, preparation method and application thereof |
| 02/27/2013 | CN101213301B Rnai for control of insects and arachnids |
| 02/27/2013 | CN101128592B Gene delivery system containing decorin gene and pharmaceutical composition for treating cancer containing the system |
| 02/27/2013 | CN101018860B Flavivirus vaccine |
| 02/26/2013 | US8386898 Method and apparatus for data transmission using multiple transmit antennas |
| 02/26/2013 | US8386191 Method for quantifying initial concentration of nucleic acid from real-time nucleic acid amplification data |
| 02/26/2013 | US8383918 Wheat variety 25R34 |
| 02/26/2013 | US8383917 Wheat variety W00600H3 |
| 02/26/2013 | US8383916 Maize variety hybrid X05B936 |
| 02/26/2013 | US8383913 Maize variety hybrid X85A661 |
| 02/26/2013 | US8383912 Maize variety hybrid X7K442 |
| 02/26/2013 | US8383911 Maize variety hybrid X13A467 |
| 02/26/2013 | US8383910 Maize variety hybrid X8K858 |
| 02/26/2013 | US8383909 Maize variety hybrid X08A117 |
| 02/26/2013 | US8383908 Maize variety hybrid X03A121 |
| 02/26/2013 | US8383906 Maize variety hybrid X13A494 |
| 02/26/2013 | US8383905 Maize variety hybrid X08A147 |
| 02/26/2013 | US8383904 Maize variety hybrid X18A645 |
| 02/26/2013 | US8383902 Plants and seeds of hybrid corn variety CH999541 |
| 02/26/2013 | US8383901 ODP1-2 genes and uses thereof in plants |
| 02/26/2013 | US8383900 Soybean variety XB15C11 |
| 02/26/2013 | US8383899 Soybean variety XB17V11 |
| 02/26/2013 | US8383898 Soybean variety A1023788 |
| 02/26/2013 | US8383897 Soybean variety A1023763 |
| 02/26/2013 | US8383896 Soybean variety A1023758 |
| 02/26/2013 | US8383895 Soybean variety A1024198 |
| 02/26/2013 | US8383892 Soybean variety A1015895 |
| 02/26/2013 | US8383891 Wuschel (WUS) gene homologs |
| 02/26/2013 | US8383890 Genes encoding fatty acid desaturases from Sorghum bicolor |
| 02/26/2013 | US8383889 Transgenic plants modified for reduced cadmium transport, derivative products, and related methods |
| 02/26/2013 | US8383887 Methods of using plants containing the gdhA gene |
| 02/26/2013 | US8383880 Infertility control of genetically modified fish |
| 02/26/2013 | US8383879 Non-human animal disease mode for hepatitis B virus-associated disease |
| 02/26/2013 | US8383807 MicroRNA and methods for inhibiting same |
| 02/26/2013 | US8383805 RNAi modulation of SCAP and therapeutic uses thereof |
| 02/26/2013 | US8383804 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof |
| 02/26/2013 | US8383803 PITX3 expression promoters |
| 02/26/2013 | US8383802 Nucleic acids encoding antibodies that bind factor D |
| 02/26/2013 | US8383799 Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
| 02/26/2013 | US8383797 Luciferase gene optimized for use in imaging of intracellular luminescence |
| 02/26/2013 | US8383793 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors |
| 02/26/2013 | US8383790 Modified surface antigen |
| 02/26/2013 | US8383789 Vasopressin-binding L-nucleic acid |
| 02/26/2013 | US8383788 For therapy of cancer or tumorous growth |
| 02/26/2013 | US8383775 Cytokine zalpha11 ligand |
| 02/26/2013 | US8383774 Collectin fusion proteins comprising TNF or trail |
| 02/26/2013 | US8383766 Zinc finger protein for use as transcriptional modulator |
| 02/26/2013 | US8383604 Modulation of BCL11A for treatment of hemoglobinopathies |
| 02/26/2013 | US8383603 Means and methods for counteracting, delaying and/or preventing heart disease |
| 02/26/2013 | US8383601 Tissue specific gene therapy treatment |
| 02/26/2013 | US8383600 Increasing glucose transport and insulin-stimulated glucose uptake |
| 02/26/2013 | US8383599 Methods and compositions for RNA interference |
| 02/26/2013 | US8383598 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 02/26/2013 | US8383568 Polyol oxidases |
| 02/26/2013 | US8383402 Trichoplusia ni cell line and methods of use |
| 02/26/2013 | US8383401 T-cell receptor and nucleic acid encoding the receptor |
| 02/26/2013 | US8383400 Kits for producing recombinant polypeptides via cysteine protease autoprocessing of fusion proteins |
| 02/26/2013 | US8383399 Nucleic acid construct having an ovalbumin promotor |
| 02/26/2013 | US8383398 Expression vector |
| 02/26/2013 | US8383394 System and method for electroporating a sample |
| 02/26/2013 | US8383389 Hydroxynitrile lyase |
| 02/26/2013 | US8383388 for oral administration; exhibit increased protein stability; exhibit increased stability in the bloodstream, following oral administration, and/or under storage conditions |
| 02/26/2013 | US8383387 Subtilases |
| 02/26/2013 | US8383383 Polypeptides having lipase activity and polynucleotides encoding same |
| 02/26/2013 | US8383377 Bacterium capable of fermenting glucose, mannose and xylose simultaneously, and method for production of bioethanol using the bacterium |
| 02/26/2013 | US8383371 Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2a, and a cell having such nucleic acid construct introduced therein |
| 02/26/2013 | US8383370 Modified RNA ligase for efficient 3′ modification of RNA |
| 02/26/2013 | US8383367 IL-21 variant nucleic acids |
| 02/26/2013 | US8383366 Enhanced protein expression in Bacillus |
| 02/26/2013 | US8383348 Precircle probe nucleic acid amplification methods |
| 02/26/2013 | US8383126 Bacterial pheromones and uses thereof |
| 02/26/2013 | US8383117 CD44E tumor specific antibody |
| 02/26/2013 | US8383107 Single domain brain-targeting antibody fragments derived from llama antibodies |
| 02/26/2013 | US8383102 Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
| 02/26/2013 | US8383095 Methods and compositions for enhancing engraftment of hematopoietic stem cells |
| 02/26/2013 | US8383091 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2633345C A method of affinity separation and ligands for use therein |
| 02/26/2013 | CA2632013C Adenovirus 36 e4 orf 1 gene and protein and their uses |
| 02/26/2013 | CA2600882C Chemically inducible expression of biosynthetic pathways |
| 02/26/2013 | CA2542035C Process for producing antithrombin iii composition |
| 02/26/2013 | CA2509979C Alphavirus particles and methods for preparation |
| 02/26/2013 | CA2509973C Multi-antigenic alphavirus replicon particles and methods |
| 02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
| 02/26/2013 | CA2493406C Gm-negative ehv-mutants without heterologous elements |
| 02/26/2013 | CA2488668C Modifying the dna recombination potential in eukaryotes |